Evaluate the Tolerance, Safety and Pharmacokinetics of Germinal Peptide Eye Drops in Healthy Volunteers

NCT03662971 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Corneal Defect

Interventions

DRUG: Germinal peptide eye drops

Sponsor

Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.